Literature DB >> 31481801

Time from autologous to allogeneic hematopoietic stem cell transplantation impacts post-transplant outcomes in multiple myeloma.

Salvatore Fiorenza1, David Routledge2, Jenny Collins2, Michael Shipton3, Simon Harrison2, Ashish Bajel2, James Cavet3, Eleni Tholouli4, Jordan Gauthier5, David Ritchie6.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 31481801     DOI： 10.1038/s41409-019-0642-x

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  3 in total

1.  Application of urine immunofixation electrophoresis in prognostic evaluation of hematopoietic stem cell transplantation in patients with myeloma.

Authors:  Shanshan Zhu; Chao Yang; Wei Li; Meilin Lin
Journal:  Pak J Med Sci       Date:  2022 Jan-Feb       Impact factor: 1.088

Review 2.  Allogeneic Stem Cell Transplantation in Multiple Myeloma.

Authors:  Christine Greil; Monika Engelhardt; Jürgen Finke; Ralph Wäsch
Journal:  Cancers (Basel)       Date:  2021-12-23       Impact factor: 6.639

3.  Identification of three immune molecular subtypes associated with immune profiles, immune checkpoints, and clinical outcome in multiple myeloma.

Authors:  Guangtao Gao; Mengkun Fang; Peipei Xu; Bing Chen
Journal:  Cancer Med       Date:  2021-08-21       Impact factor: 4.452
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.